See more : American International Group, Inc. (AIG.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Prostatype Genomics AB (publ) (PROGEN.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Prostatype Genomics AB (publ), a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- PT Alumindo Light Metal Industry Tbk (ALMI.JK) Income Statement Analysis – Financial Results
- Bhandari Hosiery Exports Limited (BHANDARI.NS) Income Statement Analysis – Financial Results
- Life Foods Co., Ltd. (3065.T) Income Statement Analysis – Financial Results
- Peer to Peer Network (PTOP) Income Statement Analysis – Financial Results
- Nakoda Group of Industries Limited (NGIL.BO) Income Statement Analysis – Financial Results
Prostatype Genomics AB (publ) (PROGEN.ST)
Industry: Medical - Diagnostics & Research
Sector: Healthcare
Website: https://www.prostatypegenomics.com
About Prostatype Genomics AB (publ)
Prostatype Genomics AB manufactures, markets, and sells the prognostic gene tests. It offers Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, Gleason Score, and Tumor Stage, as well as calculates the P-score. The test is based on database containing prostate cancer patients and provides decision support for patients and doctors when making a treatment decision. The company was founded in 2007 and is based in Solna, Sweden.
| Metric | 2023 | 2022 | 2021 | 2020 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.36M | 682.80K | 10.00K | 683.88K | 74.09K | 161.84K | 5.00M | 101.50K |
| Cost of Revenue | 19.45M | 25.78M | -2.50M | 14.89M | -3.23M | -4.66M | 4.97M | 6.16M |
| Gross Profit | -18.09M | -25.10M | 2.51M | -14.20M | 3.31M | 4.82M | 29.76K | -6.06M |
| Gross Profit Ratio | -1,334.07% | -3,675.84% | 25,093.91% | -2,077.01% | 4,465.64% | 2,980.11% | 0.60% | -5,966.51% |
| Research & Development | 3.23M | 3.51M | 1.49M | 2.41M | 1.25M | 2.52M | 2.06M | 2.21M |
| General & Administrative | 0.00 | 13.49M | 8.49M | 0.00 | 5.11M | 6.49M | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 18.49M | 13.49M | 8.49M | 5.95M | 5.11M | 6.49M | 2.49M | 3.02M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 3.23M | 29.37M | 18.06M | 2.41M | 11.17M | 13.99M | 4.66M | 5.33M |
| Cost & Expenses | 40.66M | 29.37M | 15.56M | 17.30M | 7.94M | 9.33M | 9.62M | 11.49M |
| Interest Income | 4.00K | 0.00 | 0.00 | 0.00 | 0.00 | 3.08K | 121.10K | 99.26K |
| Interest Expense | 1.54M | 396.24K | 81.49K | 1.49M | 684.24K | 156.90K | 0.00 | 0.00 |
| Depreciation & Amortization | 1.88M | 1.90M | 88.48K | 149.05K | 154.14K | 194.58K | 106.51K | 106.51K |
| EBITDA | -38.02M | -26.79M | -15.46M | -15.76M | -7.71M | -8.97M | -4.52M | -11.28M |
| EBITDA Ratio | -2,803.83% | -3,922.97% | -154,582.36% | -2,408.24% | -10,403.65% | -5,540.26% | -90.46% | -11,117.52% |
| Operating Income | -39.31M | -28.69M | -15.55M | -16.62M | -7.86M | -9.16M | -4.63M | -11.39M |
| Operating Income Ratio | -2,898.67% | -4,201.87% | -155,467.10% | -2,430.03% | -10,611.71% | -5,662.39% | -92.59% | -11,222.45% |
| Total Other Income/Expenses | -2.13M | -397.53K | -81.49K | -789.78K | -684.24K | -153.83K | -121.10K | -99.26K |
| Income Before Tax | -41.44M | -29.09M | -15.63M | -17.41M | -8.55M | -9.32M | -4.75M | -11.49M |
| Income Before Tax Ratio | -3,055.68% | -4,259.90% | -156,281.95% | -2,545.52% | -11,535.30% | -5,757.43% | -95.02% | -11,320.24% |
| Income Tax Expense | 0.00 | 1.68M | -148.08K | -2.00 | -7.00K | 3.08K | 0.00 | 0.00 |
| Net Income | -41.44M | -29.09M | -15.63M | -17.41M | -8.55M | -9.32M | -4.75M | -11.49M |
| Net Income Ratio | -3,055.68% | -4,259.90% | -156,281.95% | -2,545.52% | -11,535.30% | -5,757.43% | -95.02% | -11,320.24% |
| EPS | -0.24 | -0.33 | -0.23 | -0.25 | -0.31 | -0.33 | -0.17 | -0.41 |
| EPS Diluted | -0.24 | -0.33 | -0.23 | -0.25 | -0.31 | -0.33 | -0.17 | -0.41 |
| Weighted Avg Shares Out | 172.07M | 88.44M | 68.98M | 69.02M | 27.98M | 27.98M | 27.98M | 27.98M |
| Weighted Avg Shares Out (Dil) | 172.07M | 88.44M | 68.98M | 69.02M | 27.98M | 27.98M | 27.98M | 27.98M |
Source: https://incomestatements.info
Category: Stock Reports